Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.90
+0.44 (2.38%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Fulgent Genetics Employees
Fulgent Genetics had 1,313 employees as of December 31, 2024. The number of employees increased by 129 or 10.90% compared to the previous year.
Employees
1,313
Change (1Y)
129
Growth (1Y)
10.90%
Revenue / Employee
$215,895
Profits / Employee
-$32,527
Market Cap
583.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
FLGT News
- 13 days ago - Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025 - Business Wire
- 19 days ago - Stock Picks From Seeking Alpha's March 2025 New Analysts - Seeking Alpha
- 5 weeks ago - Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy - Seeking Alpha
- 7 weeks ago - Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 7 weeks ago - Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025 - Business Wire
- 2 months ago - Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics - Business Wire
- 4 months ago - Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside - Seeking Alpha